Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer
Clinical trial NCT00016549 · COMPLETED
Trial details
- NCT number
- NCT00016549
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-13
- Primary completion
- 2007-01-29
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.